|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 409 12th Street, SW |
Address2 |
|
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Kira Peterson |
Date | 7/19/2024 1:50:14 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; Impact of abortion restrictions on patient outcomes and the ob-gyn workforce (general); H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Inclusion of pregnant and lactating individuals in research (general); Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; H.R. 7056/S. 3612, Access to Family Building Act; H.R. 7153/S. 3679, Dr. Lorna Breen Health Care Provider Protection Act; S.___, Supporting Healthy Moms and Babies Act; S. 712/H.R. 8532, Connected MOM Act; S. 4079/H.R. 8383, Rural Obstetrics Readiness Act; H.R.___, PRAMS for Dads Act; S. 4223, Access to Birth Control Act; H.Res.1248, National Menstrual Health Awareness Month Resolution; Diversity, Equity, and Inclusion in medicine (general); H.R 8715, NEST Act; S.___, Keep Obstetrics Local Act; H.R. 7855, Rural Residency Planning and Development Act; H.R.___, Diane Powis Ovarian Cancer Testing Access Act; H.R. 8247, Uterine Fibroids Intervention and Gynecological Health Treatment Act (UFIGHT); H.R. 4933/S. 462, Mental Health Professionals Workforce Shortage Loan Repayment Act; H.R. 7432, Sickle Cell Disease Comprehensive Care Act of 2024; S. 4445, Right to IVF Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; H.R. 834/S. 230, Rural Physician Workforce Production Act; Rural Residency Planning and Development Program (general); National Health Service Corps (general); H.R. 3523/S. 1710, Perinatal Workforce Act; H.R. 3086, Find it Early Act; H.R. 8796/S. 4619, Stop Comstock Act; Health Insurance Portability and Accountability Act (general); Patient-physician relationship (general); Menopause research, training, and education (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Physician burnout (general); Maternal mental health (general); Artificial intelligence in health care (general); Coverage for infertility (general); Protections for in vitro fertilization (general); Restrictions on menthol cigarettes and flavored cigars (general); Nicotine limits in cigarettes (general); White House Initiative on Womens Health Research (general); Pediatric Subspecialty Loan Repayment Program; Over-the-counter contraception (general); HPV vaccination (general); Cancer Moonshot Initiative; Remote patient monitoring (general); Fertility preservation services for sickle cell patients treated with cell and gene therapies; Prenatal screening (general);Prenatal supplements (general); Crisis pregnancy centers (general); Care for pregnant and postpartum incarcerated individuals (general); Congenital syphilis (general); Gun violence as a public health issue (general); Obstetric hemorrhage managements at the Indian Health Service (general); H.Res. 1180, Recognizing the importance of diversity, equity, and inclusion efforts in medical education.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), White House Office, Centers For Disease Control & Prevention (CDC), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Erin |
Alston |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
|
Lisa |
Satterfield |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2474, Strengthening Medicare for Patients and Providers Act; Physician payment under Medicare (general); H.R. 6683, Preserving Seniors' Access to Physicians Act; Graduate medical education (general); Prior authorization in Medicare (general); Medicaid free choice of provider requirement; Implementation of P.L. 117-328, Consolidated Appropriations Act, including permanent option for postpartum Medicaid extension; Physician reimbursements under Medicaid (general); Site-neutral Medicare reimbursements (general); S. 4532/H.R. 8702, Improving Seniors Timely Access to Care Act; S. 4338, Pay PCPs Act; H.R. 8839, Maternal and Newborn Health Protection Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Erin |
Alston |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
|
Lisa |
Satterfield |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Abortion care at the Department of Veterans Affairs (general); coverage of in vitro fertilization.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 4942/S. 665, Conrad State 30 and Physician Access Reauthorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Lillie |
Heyman |
|
|
|
Rachel |
Tetlow |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Alliance for Innovation on Maternal Health; Safe Motherhood and Infant Health Program; Centers for Disease Control and Prevention (CDC); CDC Office on Smoking and Health (OSH); National Center for Health Statistics (NCHS); National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Agency for Healthcare Research and Quality (AHRQ); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC); Teaching Health Center Graduate Medical Education Program; Congressionally Directed Medical Research Program; Defense Health Research Programs; Title X family planning program; Title V Maternal and Child Health Block Grant; Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); Healthy Start Program; Obstetrics and gynecology graduate medical education programs; Graduate medical education programs within the Indian Health Service; Stillbirth Working Group (HHS); Care for pregnant and postpartum incarcerated women; Definition of severe maternal morbidity; Teen Pregnancy Prevention Program; Division of Adolescent and School Health; Office of Research on Womens Health (ORWH); Surveillance for Emerging Threats to Moms and Babies (SET-NET); National Center for Environmental Health; Agency for Toxic Substances and Disease Registry; CDC emergency relief funds (general); Tobacco user fees (general); CDC Division of Sexually Transmitted Disease Prevention; Firearm morbidity and mortality prevention research (general); STI clinical support resources (general); Center for Substance Abuse Treatment (CSAT) Pregnant and Postpartum Womens (PPW) Residential Services Grant Program; Bias training for health care providers (general); Rural Obstetric Network Grants; Rural Maternal and Obstetric Care Training Demonstration Program; NIH restructuring; Neglected surgical conditions (USAID); Title VII Health Professions and Title VIII Nursing Workforce Development programs; Building Interdisciplinary Research Careers in Womens Health (BIRCWH) program; the NICHD Womens Reproductive Health Research (WRHR) career development program; Hyde Amendment; Weldon Amendment; STI clinical services (general); Abstinence-only programs (general); HHS Office of Civil Rights; Contraceptive research (general); Abortion research (general); Global Gag Rule; International family planning/reproductive health programs (general); United Nations Population Fund; Helms Amendment; International reproductive rights reporting (general); HIV Working Capital Fund; Kemp-Kasten Amendment; Abortion access (general); Abortion coverage for federal employees and District of Columbia residents; Abortion coverage for federal inmates; Abortion coverage for Peace Corps volunteers; Abortion access for servicemembers and veterans; Gender-affirming care (general); Contraception (general); Planned Parenthood; Abortion training for medical residents; FY2025 nondefense discretionary funding (general) FY2025 Labor, Health and Human Services, and Education, and Related Agencies appropriations bill; FY2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill; FY2025 State, Foreign Operations, and Related Programs appropriations bill; FY2025 Defense appropriations bill; FY2025 Military Construction, Veterans Affairs, and Related Agencies appropriations bill; FY2025 Interior, Environment, and Related Agencies appropriations bill.
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Lillie |
Heyman |
|
|
|
Lisa |
Satterfield |
|
|
|
Taylor |
Platt |
|
|
|
Erin |
Alston |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Access to maternity care for servicemembers and dependents (general); coverage of in vitro fertilization under TRICARE;; S. 1527, Access to Contraception for Servicemembers and Dependents Act; Coverage of midwifery care under TRICARE; Remote blood pressure monitoring for TRICARE beneficiaries.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Lillie |
Heyman |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 7725/S. 4115, Embracing anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Lillie |
Heyman |
|
|
|
Sarah |
Bogdan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |